OTC

Strength

20; 380; 60 mg/1; mg/1; mg/1

NDC

50991021401

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

9/17/2025

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M012

On Market Since

6/17/2013

Pharmacological Classes

Adrenergic alpha-Agonists
Decreased Respiratory Secretion Viscosity
Expectorant
Increased Respiratory Secretions
Sigma-1 Agonist
Sigma-1 Receptor Agonists
Uncompetitive N-methyl-D-aspartate Receptor Antagonist
Uncompetitive NMDA Receptor Antagonists
alpha-Adrenergic Agonist

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

-0.0%

3Y

-4.3%

5Y

-4.3%

All

-4.3%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.